Cannabidiol shows promise in treating cognitive disorders

Research reviews the therapeutic potential of cannabidiol (CBD) in treating cognitive impairments, highlighting positive effects in some trials while emphasizing the need for more comprehensive studies.

FDA grants priority review for Novartis’ leukaemia treatment

Novartis’ ASC4FIRST study enrolled 405 adult patients. Credit: Melnikov Dmitriy / Shutterstock. The US Food and Drug Administration (FDA) has granted priority review designation for

July 30, 2024

Kanna-This Legal Psychoactive Holds Promise for Stress & Anxiety

Kanna, also known as Channa or Kougoed, is a plant native to South Africa that has been used for centuries as a traditional medicine for

July 11, 2023

Possible cyber attack on aap – Biotech Investments

aap Implantate AG / Key word(s): Miscellaneous aap Implantate AG: Possible cyber attack on aap 15-Oct-2024 / 23:25 CET/CEST Disclosure of an inside information acc.

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.